|
Advances in Gyn Testing
Our pathologists:
-
Strive to
continually provide the best and
cutting edge technology to
patients and healthcare
providers.
-
Investigate,
research, and invest in the best
possible testing methods.
-
Use the latest
advances in Pap testing. This
includes Cytyc’s ThinPrep™ Pap
test. Also, PCNM was the first
in the state of New Mexico to
utilize Cytyc’s Image Directed
Cytology™ System, which improves
the accuracy of the ThinPrep™
Pap test.
-
Utilize
additional (ancillary) testing
via the specimen contained in
the ThinPrep™ vial. With this
advance in testing, three
diagnoses can be rendered from
one specimen. These include the
Pap test results, HPV (human
papillomavirus) presence or
absence, and sexually
transmitted diseases (gonorrhea
and chlamydia) testing.

What does that mean
to you, our patient?
-
The ThinPrep™ Pap
test detects abnormal cells in
the cervix better than the
conventional Pap test.
-
Image Directed
Cytology™ improves the accuracy
of the ThinPrep™ Pap test.
-
Having a Pap test
at regular intervals helps you
better manage your health and
prevent cancer through early
detection.
-
80% of women do
not exhibit symptoms of
chlamydia. Using the specimen
contained in the ThinPrep™ vial,
you can be also be tested for
chlamydia and gonorrhea at the
same time at your annual
examination and Pap test.
-
The test for
presence of HPV can also be
performed from the same ThinPrep™
vial. The presence or absence of
HPV guides your clinician in
deciding what the best course of
care will be.
-
With a negative
HPV and a negative Pap test, it
is most likely you will not
develop a significant cervical
lesion in the next three to five
years.
Our goal:
Combine advantages of
the liquid-based cytology of the
ThinPrep™ Pap test, with Image
Directed Cytology™, and ancillary
testing such as for HPV and sexually
transmitted disease; thus increasing
the likelihood of early detection of
cervical cancer, thereby saving
lives and providing better
gynecologic health overall. |